The Michigan Department of Health and Human Services (MDHHS) has partnered with Vital Strategies to study buprenorphine prescribing practices, barriers, and facilitators for the treatment of opioid use disorder. All X-waivered physicians in Michigan are invited to participate in a survey that will launch on Tuesday, July 13th.
On average, participants have completed the survey in 15 – 20 minutes. Upon completing the survey, you will have the option to receive a $20 gift certificate or donate $20 to a charity. Your participation in this survey will be instrumental to informing revisions to the Michigan Department of Licensing and Regulatory Affairs’ (LARA’s) Substance Use Disorder Service Program administrative rules.
Please look out for an email from MDHHS inviting you to participate in the survey. The email will include a unique identifier code that you will be instructed to enter at the beginning of the survey to complete the survey. For additional information, please visit this survey overview webpage. If you have any questions about the survey, please email Valencia Lyle, the survey lead, at lylev@michigan.gov.